Vice President Warns AI Cannot Supplant Doctors at AIIMS Convocation

On the afternoon of the twelfth day of May in the year of our Lord two thousand and twenty‑six, the Honourable Vice‑President of the Republic of India, Shri Jagdeep Dhankhar, addressed the newly sworn graduates of the All India Institute of Medical Sciences in a ceremony that was attended by senior faculty, dignitaries, and the families of the graduating cohort, delivering a discourse which juxtaposed the marvels of contemporary artificial intelligence with the irreplaceable intimacy of the physician‑patient relationship. He asserted unequivocally, with a measured cadence befitting the gravitas of the occasion, that while algorithmic diagnostic tools may augment clinical acumen, no mechanistic system grounded solely in code can ever supplant the empathy, ethical judgment, and tactile assessment that a trained physician contributes at the bedside of a suffering patient. The Vice‑President further referenced recent governmental pronouncements that have heralded artificial intelligence as a prospective panacea for the nation’s healthcare delivery challenges, cautioning that such optimistic declarations must be tempered by empirical evidence and the immutable realities of clinical practice.

In response to the Vice‑President’s admonition, the Ministry of Health and Family Welfare issued a communiqué affirming its commitment to integrating artificial intelligence within the public health ecosystem, yet simultaneously acknowledging the necessity of preserving the centrality of human clinicians in the diagnostic and therapeutic continuum, thereby attempting to reconcile technological ambition with the time‑honored doctrine of patient‑centred care. Current pilot programmes, such as the AI‑enabled radiology triage system deployed in selected district hospitals of Uttar Pradesh and the predictive analytics platform for maternal‑child health in Karnataka, have reported modest improvements in turnaround times yet continue to encounter obstacles pertaining to data privacy, algorithmic bias, and the availability of trained personnel to interpret machine‑generated outputs. Nevertheless, critics contend that the pace of regulatory approval for such technologies remains encumbered by a labyrinthine framework of approvals, wherein the absence of clear liability statutes leaves both institutions and patients vulnerable to the repercussions of erroneous algorithmic judgments.

Given that the public purse continues to fund experimental artificial‑intelligence deployments without an accompanying transparent audit of outcomes, one must inquire whether the existing mechanisms of fiscal oversight possess sufficient rigor to safeguard taxpayer resources against unsubstantiated claims of efficiency. Furthermore, the dearth of statutory provisions delineating responsibility for diagnostic missteps attributable to algorithmic recommendations raises the vexing question of whether the legal architecture presently affords victims a viable avenue to contest institutional reliance on opaque computational determinations. Equally compelling is the contemplation of whether the present administrative discretion, which permits the integration of nascent technologies into essential health services absent robust stakeholder consultation, inadvertently marginalises the ordinary citizen’s capacity to evaluate, let alone influence, the veracity of official assurances concerning safety and efficacy. Consequently, the broader policy discourse is compelled to examine whether the current regulatory design, which simultaneously extols innovation and imposes minimal procedural safeguards, inadvertently cultivates a milieu wherein technological optimism eclipses the prudent application of evidence‑based medical standards, thereby threatening the foundational principle of patient welfare.

In light of the Vice‑President’s counsel that machines cannot inhabit the bedside, one is prompted to question whether the legislative bodies responsible for health policy have enacted sufficient oversight clauses to compel periodic independent reviews of AI‑driven clinical protocols, thereby ensuring that elected representatives remain accountable to constituencies that may otherwise be swayed by technocratic rhetoric. Moreover, the persistent reliance on vendor‑supplied performance metrics, oft‑quoted in ministerial briefings yet seldom corroborated by peer‑reviewed studies, invites scrutiny as to whether the current evidentiary standards imposed upon public procurement processes adequately protect the citizenry from unverified technological promises. Additionally, the prospect of algorithmic triage influencing admission decisions raises the profound legal dilemma of whether individuals’ rights to informed consent and to contest medical determinations are being eroded by opaque decision‑support systems that operate beyond the reach of conventional judicial review. Finally, the enduring public narrative that AI constitutes an inevitable progression toward universal health coverage compels the interrogation of whether elected officials, in their zeal to showcase modernisation, are inadvertently diminishing the electorate’s capacity to demand transparent, evidence‑based explanations for the allocation of scarce medical resources.

Published: May 12, 2026